National Assembly set to screen 38 bills

The National Assembly’s Health and Welfare Committee is expected to examine a total of 38 bills on November 9, including a bill to seek an approval of autologous cell therapy (ACT) with a Phase I study data only, when it is intended for treatment of rare, intractable or life-threatening diseases.

ACT is a novel therapeutic intervention that uses an individual’s cells, which are cultured and ...